Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL5127809 | 0.98 | ALDH1A1 (0.47) | ALDH1A1KDM4ETDP1DNM1MEN1 | |
| SCHEMBL4649332 | 0.78 | ALDH1A1 (0.42) | ALDH1A1KDM4ETDP1DNM1MEN1 | |
| SCHEMBL564456 | 0.78 | ALDH1A1 (0.50) | ALDH1A1KDM4ETDP1DNM1MEN1 | |
| Bromide SCHEMBL5117868 | 0.77 | ALDH1A1 (0.41) | ALDH1A1KDM4ETDP1DNM1MEN1 | |
| SCHEMBL28256353 | 0.76 | ALDH1A1 (0.48) | ALDH1A1KDM4ETDP1DNM1MEN1 | |
| Hydrochloric Acid SCHEMBL31362231 | 0.76 | ALDH1A1 (0.54) | ALDH1A1KDM4ETDP1DNM1MEN1 | |
| SCHEMBL28423034 | 0.74 | KDM4E (0.47) | ALDH1A1KDM4ETDP1DNM1MEN1 | |
| Bromide SCHEMBL11060577 | 0.74 | ALDH1A1 (0.47) | ALDH1A1KDM4ETDP1DNM1MEN1 | |
| SCHEMBL6624834 | 0.73 | ALDH1A1 (0.45) | ALDH1A1KDM4ETDP1DNM1MEN1 | |
| SCHEMBL28021011 | 0.73 | ACHE (0.57) | ALDH1A1KDM4ETDP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080312268-A1 | Substituted tricyclic piperidone compounds | GRUENENTHAL GMBH (DE) | 2008-12-18 | — | — | US | disclosed |
| EP-1966138-A2 | SUBSTITUTED TRICYCLIC PIPERIDONE DERIVATIVES | Grünenthal GmbH (DE) | 2008-09-10 | — | — | EP | disclosed |
| WO-2007079929-A2 | SUBSTITUTED TRICYCLIC PIPERIDONE DERIVATIVES | Grünenthal GmbH (DE) | 2007-07-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080312268-A1 | Substituted tricyclic piperidone compounds | ITCH, OPRD1, OPRK1 | ALDH1A1 6/4885KDM4E 2915/4885TDP1 2925/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.